Teleflex Inc TFX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
-
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
-
Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026
-
Teleflex Announces Quarterly Dividend
-
Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
-
Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion
-
Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma
-
Teleflex Announces Second Quarter 2026 Earnings Conference Call Information
Trading Information
- Previous Close Price
- $126.11
- Day Range
- $124.01–127.12
- 52-Week Range
- $100.18–145.00
- Bid/Ask
- $99.66 / $143.99
- Shares Outstanding
- 42.37M
- Market Cap
- $5.26B
- Volume/Avg
- 646,994 / 640,194
Key Statistics
- Price/Earnings (Normalized)
- 14.41
- Price/Sales
- 2.74
- Dividend Yield (Trailing)
- 1.10%
- Dividend Yield (Forward)
- 1.10%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 5.85%
Company Profile
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 15,500
- Website
- https://www.teleflex.com
Valuation
|
Metric
|
TFX
|
|---|---|
Price/Earnings (Normalized) | 14.41 |
Price/Book Value | 1.84 |
Price/Sales | 2.74 |
Price/Cash Flow | — |
Price/Earnings
TFX
Financial Strength
|
Metric
|
TFX
|
|---|---|
Quick Ratio | 0.92 |
Current Ratio | 2.60 |
Interest Coverage | −0.62 |
Quick Ratio
TFX
Profitability
|
Metric
|
TFX
|
|---|---|
Return on Assets (Normalized) | 6.46% |
Return on Equity (Normalized) | 13.45% |
Return on Invested Capital (Normalized) | 8.87% |
Return on Assets
TFX
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|?ny?QQ% | LOCK|G!$ | $138B | |||
| Becton Dickinson & Co
BDX
| LOCK|KkF | LOCK|s!%B< | $48B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|k%@SMB | LOCK|^>W&@ | $31B | |||
| ResMed Inc
RMD
| LOCK|D<zwc<^ | LOCK|!<X#x | $31B | |||
| Alcon Inc
ALC
| LOCK|KC@JR!@ | LOCK|<WmcH | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|H<>TTgy | LOCK|NS | $26B | |||
| Solventum Corp
SOLV
| LOCK|!?qXWnx | LOCK|s#& | $15B | |||
| Baxter International Inc
BAX
| LOCK|GR | LOCK|pX?zD | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|DxfbNw% | LOCK|jQD^ | $11B | |||
| Repligen Corp
RGEN
| LOCK|p<PTQD! | LOCK|#rRR | $10B |
United States